Sign up to save your podcasts
Or
Share ARVO 2025 Highlight: Atsena’s XLRS Gene Therapy Provides Vision and Structural Improvements in Phase 1/2 Clinical Trial
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
ARVO 2025 Highlight: Atsena’s XLRS Gene Therapy Provides Vision and Structural Improvements in Phase 1/2 Clinical Trial
Part B of the trial will enroll nine adult patients as well as three pediatric patients.
View all episodes
By Foundation Fighting Blindness
4.9
2323 ratings
Part B of the trial will enroll nine adult patients as well as three pediatric patients.
More shows like Foundation Fighting Blindness
View all
Science Friday
6,244 Listeners
Wait Wait... Don't Tell Me!
38,598 Listeners
Radio Diaries
1,261 Listeners
Fresh Air
37,887 Listeners
Freakonomics Radio
32,094 Listeners
TED Radio Hour
21,966 Listeners
Retirement Answer Man
1,289 Listeners
CBS News Sunday Morning with Jane Pauley
1,041 Listeners
Hidden Brain
43,712 Listeners
The New Yorker Radio Hour
6,664 Listeners
The Dr. Hyman Show
9,294 Listeners
Meditative Story
3,072 Listeners
Fiction - Comedy Fiction
6,445 Listeners
Pediatrics On Call
228 Listeners
Today's Tips from AARP
433 Listeners